These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12878816)

  • 1. [BK virus-associated nephropathy].
    Kaltenis P
    Medicina (Kaunas); 2003; 39(7):637-9. PubMed ID: 12878816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of polyomavirus infection with cidofovir in a renal-transplant recipient.
    Bjorang O; Tveitan H; Midtvedt K; Broch LU; Scott H; Andresen PA
    Nephrol Dial Transplant; 2002 Nov; 17(11):2023-5. PubMed ID: 12401867
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of cidofovir in polyomavirus BK viral nephropathy in two renal allograft recipients.
    Lim WH; Mathew TH; Cooper JE; Bowden S; Russ GR
    Nephrology (Carlton); 2003 Dec; 8(6):318-23. PubMed ID: 15012704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults.
    Vats A; Shapiro R; Singh Randhawa P; Scantlebury V; Tuzuner A; Saxena M; Moritz ML; Beattie TJ; Gonwa T; Green MD; Ellis D
    Transplantation; 2003 Jan; 75(1):105-12. PubMed ID: 12544881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BK transplant nephropathy successfully treated with cidofovir.
    Keller LS; Peh CA; Nolan J; Bannister KM; Clarkson AR; Faull RJ
    Nephrol Dial Transplant; 2003 May; 18(5):1013-4. PubMed ID: 12686681
    [No Abstract]   [Full Text] [Related]  

  • 6. BK nephropathy: what is the role of antiviral therapy?
    Fishman JA
    Am J Transplant; 2003 Feb; 3(2):99-100. PubMed ID: 12614295
    [No Abstract]   [Full Text] [Related]  

  • 7. Cidofovir may be deleterious in BK virus-associated nephropathy.
    Pallet N; Burgard M; Quamouss O; Rabant M; Bererhi L; Martinez F; Thervet E; Anglicheau D; Noel LH; Rouzioux C; Legendre C
    Transplantation; 2010 Jun; 89(12):1542-4. PubMed ID: 20559110
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of refractory BK virus-associated nephropathy with cidofovir.
    Kadambi PV; Josephson MA; Williams J; Corey L; Jerome KR; Meehan SM; Limaye AP
    Am J Transplant; 2003 Feb; 3(2):186-91. PubMed ID: 12614296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cidofovir may be deleterious in BK virus-associated nephropathy.
    Hakeem A; Sharma H; Sharma A
    Transplantation; 2011 Jan; 91(2):e11-2; author reply e12. PubMed ID: 21239956
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful pregnancy in renal transplant recipient with previous known polyomavirus nephropathy.
    Midtvedt K; Bjorang O; Letting AS
    Clin Transplant; 2007; 21(4):571-3. PubMed ID: 17645722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy.
    Araya CE; Lew JF; Fennell RS; Neiberger RE; Dharnidharka VR
    Pediatr Transplant; 2006 Feb; 10(1):32-7. PubMed ID: 16499584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of BK virus-associated nephropathy with Cidofovir in renal transplantation.
    Cabello V; Margarit N; Díaz Pedrero M; Bernal G; Pereira P; Gentil MA
    Transplant Proc; 2008 Nov; 40(9):2930-2. PubMed ID: 19010151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of cidofovir treatment of polyomavirus nephropathy in kidney transplant recipients.
    Hua DK; Howard K; Craig JC; Chapman JR; Wong G
    Transplantation; 2012 Jan; 93(2):188-94. PubMed ID: 22186937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BK virus-associated nephropathy in a kidney transplant recipient successfully treated with cidofovir, the first case in Japan.
    Akioka K; Okamoto M; Ushigome H; Nobori S; Kaihara S; Yoshimura N
    Int J Urol; 2008 Apr; 15(4):369-71. PubMed ID: 18380832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observations on the use of cidofovir for BK virus infection in renal transplantation.
    Kuten SA; Patel SJ; Knight RJ; Gaber LW; DeVos JM; Gaber AO
    Transpl Infect Dis; 2014 Dec; 16(6):975-83. PubMed ID: 25412701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss.
    Mohamed M; Parajuli S; Muth B; Astor BC; Panzer SE; Mandelbrot D; Zhong W; Djamali A
    Transpl Infect Dis; 2016 Jun; 18(3):361-71. PubMed ID: 26998753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of low-dose cidofovir on the long-term outcome of polyomavirus-associated nephropathy in renal transplant recipients.
    Wu SW; Chang HR; Lian JD
    Nephrol Dial Transplant; 2009 Mar; 24(3):1034-8. PubMed ID: 19059933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic possibilities for polyomavirus infections in renal transplantation].
    Hurault de Ligny B; Godin M; Lobbedez T; Etienne I; El Haggan W; Pujo M; Ryckelynck JP
    Presse Med; 2003 Apr; 32(14):667-8. PubMed ID: 12714908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single-centre study of adjuvant cidofovir therapy for BK virus interstitial nephritis (BKVIN) in renal allograft recipients.
    Kuypers DR; Bammens B; Claes K; Evenepoel P; Lerut E; Vanrenterghem Y
    J Antimicrob Chemother; 2009 Feb; 63(2):417-9. PubMed ID: 19056749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.